Who are Six percent hydroxy ethyl starch 130/0.4's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Balanced hydroxyethyl starch solution, hydroxyethl starch.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/six-percent-hydroxy-ethyl-starch-130-0-4.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Six percent hydroxy ethyl starch 130/0.4 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Six percent hydroxy ethyl starch 130/0.4 (Six percent hydroxy ethyl starch 130/0.4) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Synthetic colloid / Volume expander. Area: Cardiovascular / Critical Care.

phase 3 Synthetic colloid / Volume expander Cardiovascular / Critical Care Small molecule Live · refreshed every 30 min

Target snapshot

Six percent hydroxy ethyl starch 130/0.4 (Six percent hydroxy ethyl starch 130/0.4) — Rajaie Cardiovascular Medical and Research Center. Hydroxyethyl starch (HES) 130/0.4 is a synthetic colloid that expands intravascular volume by increasing plasma oncotic pressure and maintaining fluid in the vascular space.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Six percent hydroxy ethyl starch 130/0.4 TARGET	Six percent hydroxy ethyl starch 130/0.4	Rajaie Cardiovascular Medical and Research Center	phase 3	Synthetic colloid / Volume expander
Balanced hydroxyethyl starch solution	Balanced hydroxyethyl starch solution	Rambam Health Care Campus	marketed	Synthetic colloid / volume expander
hydroxyethl starch	hydroxyethl starch	China International Neuroscience Institution	marketed	Synthetic colloid / Volume expander

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Synthetic colloid / Volume expander class)

China International Neuroscience Institution · 1 drug in this class
Rajaie Cardiovascular Medical and Research Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Six percent hydroxy ethyl starch 130/0.4 — Competitive Intelligence Brief. https://druglandscape.com/ci/six-percent-hydroxy-ethyl-starch-130-0-4. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab